Implementation facilitation to promote emergency department-initiated buprenorphine for opioid use disorder: protocol for a hybrid type III effectiveness-implementation study (Project ED HEALTH)

Table 2 Schedule of patient activities and assessments by time period

Instrument/activity	Time	Done by	Baseline evaluation period (12 months)			IF evaluation period (12 months)
			Screening	Enrollment	30-day follow-up	Screening	Enrollment	30-day follow-up
			(Index ED visit 1)		(Visit 2)	(Index ED visit 1)		(Visit 2)
ED health quiz	2′	RA	X			X
DSM-5	5′	RA	X			X
Urine drug screen	5′	RA	X			X
Patient eligibility summary	2′	RA	X			X
Written compound informed consent	10’	RA		X			X
Demographics and additional characteristics	1’	RA		X			X
Locator information form	2’	RA		X			X
Other substance use	1’	RA		X			X
Timeline followback (TLFB)	10’	RA		X	X		X	X
Health services utilization (inpatient and outpatient)	6’	RA		X	X		X	X
Health status (HRBS/PHQ9/PEG)	3’	RA		X	X		X	X
Overdose	1’	RA		X	X		X	X
EuroQol-5D	2’	RA		X	X		X	X
Crime and criminal justice	1’	RA		X	X		X	X
Urine drug screen	5’	RA			X			X
Healthcare visit logistics	1’	RA			X			X
Engagement in treatment	5’	RA			X			X
ED visit review		RA		X			X
Critical action checklist		RA^a		X			X
ED visits and hospitalizations		RA			X			X
Study completion		RA			X			X
Serious adverse event (death)		RA	As needed			As needed
Protocol deviations		RA	As needed			As needed
Total duration in minutes for participant interaction:			14’	37’	34’	14’	37’	34’

ISSN: 1748-5908